Lars Svensson, MD, PhD

Appointed
2001

Education & Fellowships

Residency - Baylor College of Medicine
Cardiothoracic Surgery
Houston, TX
1991

Fellowship - Baylor College of Medicine
Cardiovascular Surgery
Houston, TX
1989

Fellowship - Cleveland Clinic
Cardiovascular Surgery
Cleveland, OH
1987

Residency - Johannesburg General Hospital
General Surgery
Johannesburg,
1986

Medical Education - University of Witwatersrand
Johannesburg,
1986

Internship - Johannesburg General Hospital
Cardiology & Surgery
Johannesburg,
1980

Medical Education - University of Witwatersrand Faculty of Medicine
Johannesburg, South Africa,
1978

Undergraduate - Treverton College
Mooi River, South Africa 3300,
1972

Professional Highlights

• Professor of Cardiothoracic Surgery at Tufts University in Boston
• Instructor at Harvard University
• Houston VAMC Chairman of Cardiovascular Surgery
• Lahey Clinic Board of Governors, Director of Surgery Operating Rooms, and Finance Committee
• Director of Aortic Surgery Center, Cleveland Clinic
• Directs and Supervises, Cleveland Clinic Affiliate Cardiac Surgery Programs Processes and Quality of Outcomes

Certifications

• General Surgery
• Thoracic & Cardiac Surgery

Specialty Interests

Aortic valve surgery, cardiac surgery, complex aorta surgery, surgery for thoracic aortic aneurysm, endovascular aorta treatment – thoracic, heart surgery for marfan syndrome, modified david's reimplantation procedure, percutaneous valve treatment, minimally invasive heart surgery, marfan syndrome

Awards & Honors

• 2013, National Marfan Foundation, Hero with a Heart Award
• 2008, King James IV Professor of Surgery, Royal College of Surgeons of Edinburgh
• 2007, Second Place, Cleveland Clinic Top 10 Innovations of 2007
• 2000, Who's Who in Finance and Industry
• 1999, Top Doctors
• 1997, Who's Who in Medicine
• 1997, Who's Who in the World
• 1996, Who's Who in America
• 1996, Who's Who in Science and Engineering
• 1996-1998, Lahey Clinic Neurocognitive Research Grant
• 1994, Dana Fund Research Fellowship
• 1993, Lahey Clinic Research Grant
• 1992, Director's Award for Professional Leadership, Houston V.A.M.C
• 1992, V.A. Rag Research Fund Award
• 1991, DeBakey Heart Fund Research Award

Innovations & Patents

• Minimally invasive valve surgery
• Prevention of stroke and paralysis after heart surgery
• Reduction of wound infections
• Percutaneous valves
• Percutaneous aortic root replacement
• Developed techniques for aortic valve repair and bicuspid valve repair
• Developed operations for aortic arch surgery (elephant trunk procedure)
• Developed methods for reducing stroke after heart surgery
• Developed techniques to reduce paralysis after descending aortic, thoracoabdominal, and endovascular stent graft surgery
• Chaired the Expert Consensus and Guidelines Committee on the use of Endovascular Stent Grafts for Aortic Surgery

Memberships

• Fellow, Royal College of Surgeons of Edinburgh
• Fellow, South African College of Surgeons
• American College of Physician Executives
• American Association for Thoracic Surgery
• American College of Surgeons
• American College of Cardiology
• The European Association for Cardio-Thoracic Surgery

See publications for Lars Svensson, MD, PhD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/11/2024, Dr. Svensson has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Svensson receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Posthorax GmbH

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.